| Nicotinamide Riboside for Diabetic Neuropathy (NCT03685253) | University of Maryland, Baltimore | 2019-01-24 |
| Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit (NCT03183544) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-01-24 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose Administration (NCT03801967) | AstraZeneca | 2019-01-24 |
| Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG) (NCT03816696) | ViiV Healthcare | 2019-01-23 |
| Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants (NCT03806101) | Pfizer | 2019-01-23 |
| To Assess the Patients' Ability to Self-Administer Fasinumab (NCT03491904) | Regeneron Pharmaceuticals | 2019-01-23 |
| A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310 (NCT03847207) | Nxera Pharma UK Limited | 2019-01-23 |
| A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers (NCT03820180) | Respirent Pharmaceuticals Co Ltd. | 2019-01-23 |
| Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma (NCT03761108) | Regeneron Pharmaceuticals | 2019-01-23 |
| Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD (NCT03784963) | University of Chicago | 2019-01-23 |
| The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females (NCT03436745) | National Cancer Institute (NCI) | 2019-01-22 |
| Pegtibatinase as a Treatment for Patients With Classical Homocystinuria (HCU) (Also Known as the COMPOSE Study) (NCT03406611) | Travere Therapeutics, Inc. | 2019-01-22 |
| A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy Participants (NCT03811834) | Millennium Pharmaceuticals, Inc. | 2019-01-22 |
| Effects of Metformin in a Non-Diabetic Patient Population (NCT03772964) | Brian Zuckerbraun | 2019-01-22 |
| This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 (NCT03780725) | Boehringer Ingelheim | 2019-01-22 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults (NCT03829384) | ModernaTX, Inc. | 2019-01-22 |
| The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males (NCT04347005) | Arthrosi Therapeutics | 2019-01-22 |
| Trial of Cannabis for Essential Tremor (NCT03805750) | University of California, San Diego | 2019-01-22 |
| A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People (NCT03812198) | LEO Pharma | 2019-01-22 |
| CBT4CBT for Office Based Buprenorphine (NCT03580902) | CBT4CBT, LLC | 2019-01-22 |
| Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058 (NCT04069130) | Bial - Portela C S.A. | 2019-01-22 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 (NCT03838185) | Abrexa Pharmaceuticals, Inc. | 2019-01-22 |
| Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) (NCT03703167) | Memorial Sloan Kettering Cancer Center | 2019-01-22 |
| Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus (NCT03792347) | Hecheng Li M.D., Ph.D | 2019-01-21 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age (NCT03606512) | Janssen Vaccines & Prevention B.V. | 2019-01-21 |
| Non-invasive Evaluation of Cerebrovascular Reactivity in Spontaneous Intracerebral Hemorrhage (NCT03815513) | National Taiwan University Hospital | 2019-01-21 |
| Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 15 mg in Japanese Healthy Male Adult Subjects (NCT04511637) | Bayer | 2019-01-21 |
| Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants (NCT03814642) | HK inno.N Corporation | 2019-01-21 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects (NCT03706911) | Viriom | 2019-01-21 |
| This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (NCT03754660) | Bayer | 2019-01-21 |
| A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults (NCT03814590) | GlaxoSmithKline | 2019-01-21 |
| A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients (NCT03855696) | Green Cross Corporation | 2019-01-21 |
| Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma (NCT04108377) | University of California, Davis | 2019-01-21 |
| This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated (NCT03793621) | Boehringer Ingelheim | 2019-01-21 |
| A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately. (NCT03772223) | AstraZeneca | 2019-01-21 |
| Xanamem™ in Healthy Elderly Subjects (NCT03830762) | Actinogen Medical | 2019-01-21 |
| A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients (NCT03811028) | Swedish Orphan Biovitrum | 2019-01-19 |
| A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males (NCT03792477) | Pfizer | 2019-01-19 |
| Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients (NCT03812549) | Sichuan University | 2019-01-18 |
| A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002) (NCT03744637) | Merck Sharp & Dohme LLC | 2019-01-18 |
| Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial (NCT03735446) | Dana-Farber Cancer Institute | 2019-01-18 |
| A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations (NCT03810664) | OPKO Health, Inc. | 2019-01-18 |
| Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin (NCT04245046) | Midas Pharma GmbH | 2019-01-18 |
| Study of NEO-201 in Solid Tumors Expansion Cohorts (NCT03476681) | Precision Biologics, Inc | 2019-01-18 |
| A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma (NCT03852251) | Akeso | 2019-01-18 |
| Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants (NCT03735849) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-18 |
| To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer (NCT03752099) | Veru Inc. | 2019-01-18 |
| A Study to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203 (NCT02289404) | NVP Healthcare | 2019-01-18 |
| Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer (NCT03711058) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-01-17 |
| A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers (NCT03919890) | Ono Pharmaceutical Co., Ltd. | 2019-01-17 |
| Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects (NCT03947970) | Cara Therapeutics, Inc. | 2019-01-17 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431) | Fusion Pharmaceuticals Inc. | 2019-01-17 |
| Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer (NCT03810807) | Memorial Sloan Kettering Cancer Center | 2019-01-17 |
| Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder (NCT04007224) | Fundatia Bio-Forum | 2019-01-17 |
| A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together (NCT03789578) | Novo Nordisk A/S | 2019-01-17 |
| Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis. (NCT06000514) | Hospital Universitário Professor Edgard Santos | 2019-01-17 |
| Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects (NCT05389150) | Laboratorios Silanes S.A. de C.V. | 2019-01-17 |
| A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers (NCT03795519) | Cyclerion Therapeutics | 2019-01-17 |
| Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers (NCT04066257) | HK inno.N Corporation | 2019-01-17 |
| Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose (NCT03866369) | Inventiva Pharma | 2019-01-17 |
| Effects of Cladribine Tablets on the PK of Microgynon® (NCT03745144) | Merck KGaA, Darmstadt, Germany | 2019-01-17 |
| TUDCA as a Therapy for Ulcerative Colitis (UC) (NCT04114292) | Washington University School of Medicine | 2019-01-17 |
| Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients (NCT03712371) | Medical University of South Carolina | 2019-01-16 |
| IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation (NCT03564821) | Massachusetts General Hospital | 2019-01-16 |
| TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma (NCT03722342) | PharmAbcine | 2019-01-16 |
| A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects (NCT03836599) | AstraZeneca | 2019-01-16 |
| A Relative Bioavailability Food Effect Study of LY03005 (NCT03822065) | Luye Pharma Group Ltd. | 2019-01-16 |
| First-In-Man, Healthy Volunteer Study to Evaluate Safety on the Use of YQ23 (NCT03802292) | New Beta Innovation Limited | 2019-01-16 |
| NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy (NCT03589339) | Nanobiotix | 2019-01-16 |
| A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults (NCT03758612) | Global Alliance for TB Drug Development | 2019-01-16 |
| RACIN in Patients With Advanced TIL-negative Solid Tumors (NCT03728179) | Centre Hospitalier Universitaire Vaudois | 2019-01-16 |
| Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids (NCT03783988) | Trophea Development AB | 2019-01-15 |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies (NCT03607643) | Leaf Vertical Inc. | 2019-01-15 |
| A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet (NCT03783000) | Boehringer Ingelheim | 2019-01-15 |
| Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 (NCT03785249) | Mirati Therapeutics Inc. | 2019-01-15 |
| Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus (NCT03793634) | Cairo University | 2019-01-15 |
| Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser. (NCT03885895) | Kasr El Aini Hospital | 2019-01-15 |
| Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers (NCT03749460) | University of Washington | 2019-01-15 |
| A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases (NCT03800472) | Lakefront Biotherapeutics NV | 2019-01-15 |
| A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma (NCT03593187) | Assistance Publique - Hôpitaux de Paris | 2019-01-15 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects (NCT03809039) | Tanabe Pharma America, Inc. | 2019-01-15 |
| A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 (NCT03700658) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-01-15 |
| A Study of ASP1951 in Subjects With Advanced Solid Tumors (NCT03799003) | Astellas Pharma Global Development, Inc. | 2019-01-14 |
| Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma (NCT03672318) | UNC Lineberger Comprehensive Cancer Center | 2019-01-14 |
| A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects (NCT03809052) | Galecto Biotech AB | 2019-01-14 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults (NCT03849261) | Chong Kun Dang Pharmaceutical | 2019-01-14 |
| The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia (NCT03683810) | Cyprus University of Technology | 2019-01-14 |
| Study to Evaluate ASN008 Topical Gel (TG) (NCT03798561) | Asana BioSciences | 2019-01-14 |
| Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects (NCT03802487) | Sanofi | 2019-01-14 |
| WD-1603 PK Study in Healthy Volunteers (NCT03761004) | Hong Kong WD Pharmaceutical Co., Limited | 2019-01-14 |
| A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer (NCT03735290) | Mendus | 2019-01-14 |
| Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) (NCT03341676) | University Hospitals Coventry and Warwickshire NHS Trust | 2019-01-14 |
| A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer (NCT03895788) | Hunan Cancer Hospital | 2019-01-14 |
| Impact of Metformin on Immunity (NCT03713801) | The University of Texas Health Science Center at San Antonio | 2019-01-14 |
| Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients (NCT03795350) | Chiesi Farmaceutici S.p.A. | 2019-01-14 |
| A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment (NCT04811898) | Azienda Ospedaliera Universitaria Mater Domini, Catanzaro | 2019-01-14 |
| Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells (NCT02573896) | New Approaches to Neuroblastoma Therapy Consortium | 2019-01-14 |
| Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea (NCT03892772) | Brigham and Women's Hospital | 2019-01-14 |
| A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine (NCT03854110) | Persevere Therapeutics Inc. | 2019-01-14 |
| Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages. (NCT03979209) | Rush University Medical Center | 2019-01-14 |